Boston MA 胃肠道间质瘤临床试验
7项针对 胃肠道间质瘤的研究正在 Boston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
招募中3 期
- GSK Investigational Site, Boston
- GSK Investigational Site, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- Dana-Farber Cancer Institute - Oncology Department, Boston
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
招募中2 期
- Dana-Farber Cancer Institute, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
PH 2 Pemigatinib in SDH-deficient GIST
招募中2 期
- Dana Farber Cancer Institute, Boston
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
招募中1 期
- Massachusetts General Hospital, Boston
- Harvard University, Boston
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
招募中1/2 期
- Dana Farber Cancer Institute, Boston
其他城市的 胃肠道间质瘤试验
- Miami, FL8 项研究
- New York City, NY7 项研究
- Houston, TX6 项研究
- Philadelphia, PA6 项研究
- San Diego, CA5 项研究
- Nashville, TN5 项研究
- Portland, OR5 项研究
- Omaha, NE5 项研究
- Jacksonville, FL4 项研究
- Los Angeles, CA4 项研究
- Ann Arbor, MI4 项研究
- Rochester, MN4 项研究
Boston的其他研究
- 乳腺癌112 项研究
- 非小细胞肺癌90 项研究
- 癌症（所有类型）85 项研究
- 转移性癌症63 项研究
- 结直肠癌63 项研究
- 肺癌62 项研究
- 卵巢癌61 项研究
- 前列腺癌59 项研究
- 抑郁症52 项研究
- 子宫内膜癌50 项研究
- 心力衰竭44 项研究
- 急性髓系白血病44 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。